Safety Study of a Chinese Herbal Formula Simotang Oral Liquid for the Treatment of Functional Dyspepsia

NCT01232114 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2010-11-02

No results posted yet for this study

Summary

Functional dyspepsia (FD) is a common functional gastrointestinal disorder and is steadily becoming a public health problem.Simotang is a classical formula that has been used to treat gastrointestinal disorders for hundreds of years \[9\] and was approved as an oral liquid drug by the Chinese National Food and Drug Administration in the 1980s.In this study,patients with functional dyspepsia were divided according to the inclusive criteria into treatment group and control group randomly, who were given Simo decoction or Domperidone tablets for 14 days。And then the gastric emptying, Symptoms in plasma were observed before and after treatment in mult-center.

Conditions

  • Functional Dyspepsia(FD) Was Studied
  • Effect of Simotang on FD Was Studied

Sponsors & Collaborators

  • Hunan University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Liu b yan, doctor · Hunan university of TCM

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01232114 on ClinicalTrials.gov